| Item | Cat. No. | Application | Isotype |
| Anti-RhD/CD240D/RhPI mAbs [Trinbelimab Biosimilar] (MABL-5356) | MABL-5356 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-APP Abeta 1-40/42;TFRC/CD71 mAbs [Trontinemab Biosimilar] (MABL-5357) | MABL-5357 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-ITGA4B7 mAbs [Trosunilimab Biosimilar] (MABL-5358) | MABL-5358 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VSIR/VISTA/B7H5/PD1H/SISP1 mAbs [Trovostobart Biosimilar] (MABL-5359) | MABL-5359 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EPCAM/CD326 mAbs [Tucotuzumab Biosimilar] (MABL-5360) | MABL-5360 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF15/TL1A/VEGI mAbs [Tulisokibart Biosimilar] (MABL-5361) | MABL-5361 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LAG3/CD223 mAbs [Tuparstobart Biosimilar] (MABL-5362) | MABL-5362 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A mAbs [Turenkibart Biosimilar] (MABL-5363) | MABL-5363 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CEACAM5/CD66e mAbs [Tusamitamab Biosimilar] (MABL-5364) | MABL-5364 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Tuvonralimab Biosimilar] (MABL-5365) | MABL-5365 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MUC16/CA125;CD3E mAbs [Ubamatamab Biosimilar] (MABL-5366) | MABL-5366 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-MUC16/CA125;CD28 mAbs [Ubletamig Biosimilar] (MABL-5367) | MABL-5367 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-MS4A1/CD20 mAbs [Ublituximab Biosimilar] (MABL-5368) | MABL-5368 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MOX2R/CD200R1 mAbs [Ucenprubart Biosimilar] (MABL-5369) | MABL-5369 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PAUF mAbs [Ulenistamab Biosimilar] (MABL-5370) | MABL-5370 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TLR2/CD282 mAbs [Tomaralimab Biosimilar] (MABL-5339) | MABL-5339 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Tomuzotuximab Biosimilar] (MABL-5340) | MABL-5340 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Toripalimab Biosimilar] (MABL-5341) | MABL-5341 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL33 mAbs [Torudokimab Biosimilar] (MABL-5342) | MABL-5342 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-FOLR1 mAbs [Torvutatug Biosimilar] (MABL-5343) | MABL-5343 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
